A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors

Clinical trial NCT06480240 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06480240
Sponsor: OBI Pharma, Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-06-12
Primary completion: 2027-06-01
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.